Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Previous reports have suggested that some probiotics inhibit tumorigenesis and cancer progression. However, the molecules involved have not yet been identified. Here, we show that the culture supernatant of Lactobacillus casei ATCC334 has a strong tumour-suppressive effect on colon cancer cells. Using mass spectrometry, we identify ferrichrome as a tumour-suppressive molecule produced by L. casei ATCC334. The tumour-suppressive effect of ferrichrome is greater than that of cisplatin and 5-fluorouracil, and ferrichrome has less of an effect on non-cancerous intestinal cells than either of those agents. A transcriptome analysis reveals that ferrichrome treatment induces apoptosis, which is mediated by the activation of c-jun N-terminal kinase (JNK). Western blotting indicates that the induction of apoptosis by ferrichrome is reduced by the inhibition of the JNK signalling pathway. This we demonstrate that probiotic-derived ferrichrome exerts a tumour-suppressive effect via the JNK signalling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One good example is ferricrome metabolite secreted from Lactobacillus casei, able to trigger apoptosis in tumor cells via JNK pathway direct activation [44].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432
Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Van Nhieu, J. T., & Furet, J. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016393 · Cited by 842
Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K., & Polk, D. B. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.022 · Cited by 827
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., Timofeeva, O. A., Nealon, C., Dakic, A., Simic, V., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.036 · Cited by 726
New roles for bacterial siderophores in metal transport and tolerance
Schalk, I. J., Hannauer, M., & Braud, A. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02556.x · Cited by 580
Towards the Human Colorectal Cancer Microbiome
Marchesi, J. R., Dutilh, B. E., Hall, N., Peters, W. H. M., Roelofs, R., Boleij, A., & Tjalsma, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020447 · Cited by 552
Rowland, I. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.281 · Cited by 469
Jan, G., Belzacq, A.-S., Haouzi, D., Rouault, A., Métivier, D., Kroemer, G., & Brenner, C. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400935 · Cited by 385
Cited by
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,331
Gut microbiota in colorectal cancer development and therapy
Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 721
Probiotics: mechanism of action, health benefits and their application in food industries
Latif, A., Shehzad, A., Niazi, S., Zahid, A., Ashraf, W., Iqbal, M. W., Rehman, A., Riaz, T., Aadil, R. M., Khan, I. M., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1216674 · Cited by 623
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
“One good example is ferricrome metabolite secreted from Lactobacillus casei, able to trigger apoptosis in tumor cells via JNK pathway direct activation [44].”
BackgroundAnticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538
Thomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 367
“Konishi and colleagues (397) reported that the culture supernatant of L.”
BackgroundMicrobiome and colorectal cancer: Roles in carcinogenesis and clinical potential
Saus, E., Iraola-Guzmán, S., Willis, J. R., Brunet-Vega, A., & Gabaldón, T. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.001 · Cited by 350
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Sánchez-Alcoholado, L., Ramos-Molina, B., Otero, A., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez-Millán, J., & Queipo-Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12061406 · Cited by 337
“casei strain ATCC 334 produced ferrichrome, a molecule that inhibits the progression of colon cancer by inducing the apoptosis of cancer cells via c-Jun N-terminal kinase pathway [179].”
BackgroundInfluentialTargeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Ma, T., Shen, X., Shi, X., Sakandar, H. A., Quan, K., Li, Y., Jin, H., Kwok, L.-Y., Zhang, H., & Sun, Z. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.06.013 · Cited by 329
The mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · The FEBS Journal · doi:10.1111/febs.15217 · Cited by 322
A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea
Pan, J., Gong, G., Wang, Q., Shang, J., He, Y., Catania, C., Birnbaum, D., Li, Y., Jia, Z., Zhang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29672-z · Cited by 309
Gao, J., Li, Y., Wan, Y., Hu, T., Liu, L., Yang, S., Gong, Z., Zeng, Q., Wei, Y., Yang, W., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00477 · Cited by 296
“Recently, evidence demonstrates that probiotic-derived effector molecules have potential to exert intestinal protective property in the same way as their parent probiotics (Yan et al., 2007; Mazmanian et al., 2008; Sanchez et al., 2010; Konishi et al., 2016; Quévrain et al., 2016; Lebeer et al., 2018).”
BackgroundSugimura, N., Li, Q., Chu, E. S. H., Lau, H. C. H., Fong, W., Liu, W., Liang, C., Nakatsu, G., Su, A. C. Y., Coker, O. O., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-323951 · Cited by 286
“20 Interestingly, we also observed stronger tumor-suppressive effect of LGCS as compared with LCCS (online supplemental figure 5).”
BackgroundLactobacillus and intestinal diseases: Mechanisms of action and clinical applications
Huang, R., Wu, F., Zhou, Q., Wei, W., Yue, J., Xiao, B., & Luo, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127019 · Cited by 250
Probiotics for cancer alternative prevention and treatment
Legesse Bedada, T., Feto, T. K., Awoke, K. S., Garedew, A. D., Yifat, F. T., & Birri, D. J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110409 · Cited by 243
Bacterial siderophores: diversity, uptake pathways and applications
Schalk, I. J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01090-6 · Cited by 227
“For example, ferrichrome has demonstrated a robust capacity to suppress colon cancer cells without impeding the growth of non-cancerous intestinal cells 169 .”
Blum, H. E. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.04.005 · Cited by 218
The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity
Golonka, R., Yeoh, B. S., & Vijay-Kumar, M. (2019) · Journal of Innate Immunity · doi:10.1159/000494627 · Cited by 172
Yan, F., & Polk, D. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01428 · Cited by 173
“This molecule stimulates the ER stress response and c-jun N-terminal kinase (JNK) signaling though upregulation of DDIT3 gene expression, thus inhibiting growth and promoting apoptosis in colonic tumor cell lines and in a xenograft model, as reported in (85).”
ResultA. Muciniphila Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs
Fan, L., Xu, C., Ge, Q., Lin, Y., Wong, C. C., Qi, Y., Ye, B., Lian, Q., Zhuo, W., Si, J., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-1019 · Cited by 168
Targeted Delivery of Probiotics: Perspectives on Research and Commercialization
Yoha, K. S., Nida, S., Dutta, S., Moses, J. A., & Anandharamakrishnan, C. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09791-7 · Cited by 164
Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment
Rad, A. H., Aghebati-Maleki, L., Kafil, H. S., & Abbasi, A. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1765310 · Cited by 165
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
Secretome of Intestinal Bacilli: A Natural Guard against Pathologies
Ilinskaya, O. N., Владимировна, У. В., Рашидовна, Я. Д., & Гатауллин, И. Г. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01666 · Cited by 157
“casei was identified as a tumor-suppressive molecule on colon cancer cells which induces apoptosis via activation of c-jun N-terminal kinase (JNK) (Konishi et al., 2016).”
BackgroundKnackstedt, R., Knackstedt, T., & Gatherwright, J. (2020) · Experimental Dermatology · doi:10.1111/exd.14032 · Cited by 141
Zhuo, Q., Yu, B., Zhou, J., Zhang, J., Zhang, R., Xie, J., Wang, Q., & Zhao, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-56661-y · Cited by 137
Exploring the Role of Gut Microbiome in Colon Cancer
Chattopadhyay, I., Dhar, R., Pethusamy, K., Seethy, A. A., Srivastava, T. P., Sah, R., Sharma, J. N., & Karmakar, S. (2021) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-021-03498-9 · Cited by 156
Intestinal bacteria and colorectal cancer: etiology and treatment
Dougherty, M. W., & Jobin, C. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185028 · Cited by 159
Elevated Apoptosis in the Liver of Dairy Cows with Ketosis
Du, X., Chen, L., Huang, D. Y., Peng, Z., Zhao, C., Zhang, Y., Zhu, Y., Wang, Z., Li, X., & Liu, G. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480529 · Cited by 127
Gut dysbacteriosis and intestinal disease: mechanism and treatment
Meng, X., ZHANG, G., Cao, H., Yu, D., Fang, X., de Vos, W. M., & Wu, H. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14661 · Cited by 164
“In cancer, through mass spectrometric analysis, it is observed that Lactobacillus casei ATCC 334 can produce iron pigment, which plays a role in inhibiting tumour progression by activating JNK signalling pathway (Konishi et al. 2016).”
BackgroundArmstrong, H., Bording-Jorgensen, M., Dijk, S., & Wine, E. (2018) · Cancers · doi:10.3390/cancers10030083 · Cited by 118
“identified ferrichrome as the molecule produced by Lactobacillus casei which is responsible for the probiotic microbes tumor-suppressive effects [202].”
BackgroundResultProbiotics: A Promising Candidate for Management of Colorectal Cancer
Tripathy, A., Dash, J., Kancharla, S., Kolli, P., Mahajan, D., Senapati, S., & Jena, M. K. (2021) · Cancers · doi:10.3390/cancers13133178 · Cited by 133
The biological activities of postbiotics in gastrointestinal disorders
Abbasi, A., Rad, A. H., Ghasempour, Z., Sabahi, S., Kafil, H. S., Hasannezhad, P., Saadat, Y. R., & Shahbazi, N. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1895061 · Cited by 126
Sun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 127
Bacteria and bacterial derivatives as delivery carriers for immunotherapy
Kang, S., Nguyen, D.-H., Yoo, S. W., & Min, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114085 · Cited by 106
Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy
Kvaková, M., Kamlárová, A., Štofilová, J., Benetinová, V., & Bertková, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i27.3370 · Cited by 121
Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression
Torres-Maravilla, E., Boucard, A.-S., Mohseni, A. H., Taghinezhad-S, S., Cortes-Perez, N. G., & Bermúdez-Humarán, L. G. (2021) · Microorganisms · doi:10.3390/microorganisms9051021 · Cited by 96
Ranjbar, M., Salehi, R., Javanmard, S. H., Rafiee, L., Faraji, H., jafarpor, S., Ferns, G. A., Ghayour‐Mobarhan, M., Manian, M., & Nedaeinia, R. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01886-z · Cited by 119
“casei probioticderived ferrichrome has its anti-tumor effect through the pathway contributing to JNK-mediated apoptosis [92].”
BackgroundKumar, A., Green, K. M., & Rawat, M. (2024) · Foods · doi:10.3390/foods13182937 · Cited by 118
The impact of the intestinal microbiota in therapeutic responses against cancer
Goubet, A., Daillère, R., Routy, B., Derosa, L., Roberti, P. M., & Zitvogel, L. (2018) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2018.03.004 · Cited by 100
Vahed, S. Z., Barzegari, A., Saadat, Y. R., Goreyshi, A., & Omidi, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.033 · Cited by 99
Mantzourani, I., Chondrou, P., Bontsidis, C., Karolidou, K., Terpou, A., Alexopoulos, A., Bezirtzoglou, E., Galanis, A., & Plessas, S. (2019) · Annals of Microbiology · doi:10.1007/s13213-019-01467-6 · Cited by 88
“An elegant study demonstrated that ferrichrome isolated from the CM of L. casei ATCC 334 exerted anti-cancer properties both in vitro and in a mouse xenograft model (Konishi et al. 2016).”
Proteomics, Personalized Medicine and Cancer
Su, M., Zhang, Z., Zhou, L., Han, C., Huang, C., & Nice, E. C. (2021) · Cancers · doi:10.3390/cancers13112512 · Cited by 104
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 117
Postbiotics as Promising Tools for Cancer Adjuvant Therapy
Rad, A. H., Maleki, L. A., Kafil, H. S., Zavoshti, H. F., & Abbasi, A. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2021.007 · Cited by 106
An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer
Sankarapandian, V., Maran, B. A. V., Rajendran, R. L., Jogalekar, M. P., Sridharan, G., Krishnamoorthy, R., Gangadaran, P., & Ahn, B. (2022) · Life · doi:10.3390/life12010059 · Cited by 98
“[39] analysed the probiotic-derived tumour-suppressive molecule ferrochrome, which has the ability to inhibit colon cancer progression via c-jun N-terminal Figure 3.”
BackgroundProbiotics, mechanisms of action, and clinical perspectives for diarrhea management in children
do Carmo, M. S., Santos, C. I. D., Araújo, M. C., Girón, J. A., Fernandes, E. S., & Monteiro-Neto, V. (2018) · Food & Function · doi:10.1039/c8fo00376a · Cited by 75
Singh, R. P., Shadan, A., & Ma, Y. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09992-8 · Cited by 75
Chen, S., Fan, L., Lin, Y., Qi, Y., Xu, C., Ge, Q., Zhang, Y., Wang, Q., Jia, D., Wang, L., et al. (2023) · 癌症:英文版 · doi:10.1002/cac2.12469 · Cited by 76
Dahiya, D., & Nigam, P. S. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065748 · Cited by 86
Shi, Y., Meng, L., Zhang, C., Zhang, F., & Fang, Y. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126921 · Cited by 68
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Lee, J., Lee, J., Kim, J. H., Cho, N., Lee, S. H., Park, S. B., Koh, B., Kang, D., Kim, S., & Yoo, H. M. (2019) · Biomolecules · doi:10.3390/biom9100557 · Cited by 76
“Casei-derived ferrichrome exerts a tumor-suppressive effect via the JNK signaling pathway [11].”
BackgroundSmectite promotes probiotic biofilm formation in the gut for cancer immunotherapy
Han, C., Song, J., Hu, J., Fu, H., Feng, Y., Mu, R., Xing, Z., Wang, Z., Wang, L., Zhang, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108706 · Cited by 70
Probiotics in Extraintestinal Diseases: Current Trends and New Directions
Kiousi, D. E., Karapetsas, A., Karolidou, K., Panayiotidis, M. I., Pappa, A., & Galanis, A. (2019) · Nutrients · doi:10.3390/nu11040788 · Cited by 66
“Additionally, several studies have reported the anti-proliferative potential of Lactobacillus casei CFS in vitro [142,143].”
BackgroundZhong, H., Jiang, J., Hussain, M., Zhang, H., Ling, C., & Guan, R. (2025) · Advanced Science · doi:10.1002/advs.202500304 · Cited by 84
Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells
Kita, A., Fujiya, M., Konishi, H., Tanaka, H., Kashima, S., Iwama, T., Ijiri, M., Murakami, Y., Takauji, S., Goto, T., et al. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5096 · Cited by 73
“casei ATCC334, exhibited tumor-suppressive effects in colorectal cancer cells and gastric cancer cells through the induction of DNA damage inducible transcript 3 (DDIT3)‐mediated apoptosis (19,20).”
BackgroundČierniková, S., Ševčíková, A., Drgoňa, Ľ., & Mego, M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188990 · Cited by 75
Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk
Seidel, D., Azcárate-Peril, M. A., Chapkin, R. S., & Turner, N. D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.009 · Cited by 69
Yang, B., Wang, L., Nie, Y., Wei, W., & Xiong, W. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01667-2 · Cited by 70
“siJNK can suppress the activation of JNK via RNA silencing [32].”
BackgroundHuman Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 77
Shi, Y., Zhao, X., Zhao, J., Zhang, H., Zhai, Q., Narbad, A., & Chen, W. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13687 · Cited by 61
“For example, Lactobacillus casei strain ATCC 334, inhibited the progression of colon cancer by mediating apoptosis through the c-Jun N-terminal kinase pathway (Konishi et al. 2016).”
BackgroundMelatonin and Cancer: A Polyhedral Network Where the Source Matters
Bonmatí‐Carrión, M., & Tomás‐Loba, A. (2021) · Antioxidants · doi:10.3390/antiox10020210 · Cited by 63
An Update on the Effects of Probiotics on Gastrointestinal Cancers
Davoodvandi, A., Fallahi, F., Tamtaji, O. R., Tajiknia, V., Banikazemi, Z., Fathizadeh, H., Abbasi‐Kolli, M., Aschner, M., Ghandali, M., Sahebkar, A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680400 · Cited by 61
Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
Zhou, Y., Li, Q., Wu, Y., Zhang, W., Ding, L., Ji, C., Li, P., Chen, T., Feng, L., Tang, B. Z., et al. (2024) · Advanced Materials · doi:10.1002/adma.202313953 · Cited by 68
Shamekhi, S., Abdolalizadeh, J., Ostadrahimi, A., Mohammadi, S. A., Barzegari, A., Lotfi, H., Bonabi, E., & Zarghami, N. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09528-7 · Cited by 63
Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Liu, Y., Niu, L., Li, N., Wang, Y., Liu, M., Su, X., Bao, X., Yin, B., & Shen, S. (2023) · Advanced Science · doi:10.1002/advs.202205641 · Cited by 60
Cao, C., Yue, S., Lü, A., & Liang, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107321 · Cited by 67
Chondrou, P., Karapetsas, A., Kiousi, D. E., Tsela, D., Tiptiri-Kourpeti, A., Anestopoulos, I., Kotsianidis, Ι., Bezirtzoglou, E., Pappa, A., & Galanis, Α. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0183 · Cited by 59
Gut microbiota modulation: a tool for the management of colorectal cancer
Wang, Y., & Li, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03378-8 · Cited by 64
“Furthermore, the tumoricidal effect of ferrichrome on cancer cells was greater than 5-FU and cisplatin, whereas the toxicity of ferrichrome against non-cancerous intestinal cells was less than the chemotherapy agents [133].”
BackgroundZhang, Y., Ma, C., Zhao, J., Xu, H., Hou, Q., & Zhang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.15791 · Cited by 59
“Mechanistic findings have revealed that the use of probiotics could prevent CRC by reducing fecal enzyme activity [9], inducing cancer cell apoptosis and ameliorating inflammation [10–11], as well as increasing production of tumor-suppressive ferrichrome [12].”
Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
Li, W., Deng, X., & Chen, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.644454 · Cited by 57
“The inorganic polyphosphate can also induce Hsps expression and act on the integrin b1-p38 MAPK pathway, and the peptides P75 and P40 is associated with the activation of Akt cell survival pathway.”
BackgroundInfluentialImplications of Gut Microbiota in Complex Human Diseases
Yu, D., Meng, X., de Vos, W. M., Wu, H., Fang, X., & Maiti, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312661 · Cited by 56
“Lactobacillus casei ATCC334 can produce iron pigment, which plays a role in inhibiting tumor progression by activating the JNK signaling pathway [161].”
Jacouton, E., Michel, M., Torres-Maravilla, E., Chain, F., Langella, P., & Bermúdez‐Humarán, L. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03281 · Cited by 55
Siderophores for medical applications: Imaging, sensors, and therapeutics
Fan, D., & Fang, Q. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120306 · Cited by 57
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Guo, C., Kong, L., Xiao, L., Liu, K., Cui, H., Xin, Q., Gu, X., Jiang, C., & Wu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01135-y · Cited by 48
“…N -oxide (TMAO) [135, 136], neurotransmitters (including dopamine, norepinephrine, serotonin, or γ-aminobutyric acid) [137], ferrichrome [138], β-galactosidase [139], etc., enter the circulatory system through the portal vein to stimulate the TME, changing the immune state and reversing…”
BackgroundProbiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment
Thoda, C., & Touraki, M. (2023) · Microorganisms · doi:10.3390/microorganisms11081898 · Cited by 58
Anti-tumoral Effects of Recombinant Lactococcus lactis Strain Secreting IL-17A Cytokine
Jacouton, E., Torres-Maravilla, E., Boucard, A.-S., Pouderous, N., Vilela, A. P. P., Naas, I., Chain, F., Azevedo, V., Langella, P., & Bermúdez‐Humarán, L. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03355 · Cited by 47
“Keywords: Lactococcus lactis, lactic acid bacteria, IL-17A, cancer, HPV INTRODUCTION Cancer remains a serious health concern in human society worldwide and colorectal cancer (CRC), prostrate, lung, stomach, liver and breast cancers are among the major types associated with significant mortality every year (Ferlay et a…”
BackgroundInfluentialWu, L., Huang, X., Kuang, Y., Xing, Z., Deng, X., & Luo, Z. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s209947 · Cited by 44
Bacteriotherapy in gastrointestinal cancer
Soleimanpour, S., Hasanian, S. M., Avan, A., Yaghoubi, A., & Khazaei, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117754 · Cited by 47
Sobocki, B. K., Kaźmierczak-Siedlecka, K., Folwarski, M., Hawryłkowicz, V., Makarewicz, W., & Stachowska, E. (2021) · Nutrients · doi:10.3390/nu13124425 · Cited by 48
“Ferrichrome is derived from probiotic strain Lactobacillus casei ATCC334 [52] and may act against not only pancreatic cancer, but also gastric as well as colon cancer [52,53].”
Indole-3-lactic acid suppresses colorectal cancer via metabolic reprogramming
Zhou, S., Wang, K., Huang, J., Xu, Z., Yuan, Q., Liu, L., Wang, Z., Miao, J., Wang, H., Wang, T., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2508949 · Cited by 52
“These cell lines were grown at 37 ℃ with 5% CO 2 in RPMI 1640 (Gibco, 11875500BT) supplemented with 10% heat-inactivated FBS (Celligent, CG0430B), and 1% antibiotic-antimycotic (Gibco 15,140–122).”
Guo, Y., Zhang, T., Gao, J., Jiang, X., Tao, M., Zeng, X., Wu, Z. F., & Pan, D. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104290 · Cited by 46
Dey, P., & Chaudhuri, S. R. (2022) · Biology · doi:10.3390/biology11050757 · Cited by 46
Konishi, H., Isozaki, S., Kashima, S., Moriichi, K., Ichikawa, S., Yamamoto, K., Yamamura, C., Ando, K., Ueno, N., Akutsu, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90707-4 · Cited by 45
Oh, B. S., Choi, W. J., Kim, J., Ryu, S. W., Yu, S. Y., Lee, J., Park, S., Kang, S. W., Lee, J., Jung, W. Y., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.736343 · Cited by 44
The Gut Microbiome and Colorectal Cancer: An Integrative Review of the Underlying Mechanisms
Karam, F., Deghel, Y. E., Iratni, R., Dakroub, A. H., & Eid, A. H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01683-9 · Cited by 52
“This induced apoptosis and inhibition of colon cancer cell growth progression appear to be mediated by JNK, a MAP-kinase that is involved in the regulation of cellular proliferation, differentiation, and apoptosis [61, 62].”
Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation
Saha, P., Yeoh, B. S., Xiao, X., Golonka, R. M., Kumarasamy, S., & Vijay–Kumar, M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.017 · Cited by 40
Prediction model of poorly differentiated colorectal cancer (CRC) based on gut bacteria
Zhang, Q., Zhibo, Z., Jing, Z., Zhanbo, Q., Han, S., Weili, J., Jiang, L., & Han, S. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02712-w · Cited by 40
“Ferritin secreted by lactobacillus casei directly induced apoptosis of tumor cells through the JNK pathway [18].”
Patra, S., Sahu, N., Saxena, S., Pradhan, B., Nayak, S. K., & Roychowdhury, A. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.878297 · Cited by 41
Motamedi, H., Ari, M. M., Shahlaei, M., Moradi, S., Farhadikia, P., Alvandi, A., & Abiri, R. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05197-0 · Cited by 44
Molecular crosstalk between polyphenols and gut microbiota in cancer prevention
Zeb, F., Naqeeb, H., Osaili, T. M. I., Faris, M. E., Ismail, L. C., Obaid, R. S., Naja, F., Radwan, H. M., Hasan, H. A., Hashim, M. S., et al. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.01.012 · Cited by 40
Mosadegh, M., Goodarzi, N. N., & Erfani, Y. (2025) · Cancer Investigation · doi:10.1080/07357907.2024.2445528 · Cited by 52
“Additionally, certain compounds produced by probiotics, such as nisin, a bacteriocin, and ferrochrome, have exhibited tumor-suppressing properties by means of regulating apoptosis (154,155).”
Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus
Endicott, N. P., Lee, E., & Wencewicz, T. A. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00036 · Cited by 39
Lactobacillus casei Zhang exerts probiotic effects to antibiotic-treated rats
Yao, G., Cao, C., Zhang, M., Kwok, L. Y., Zhang, H., & Zhang, W. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.026 · Cited by 36
“Several studies have demonstrated the efficacy of Lactobacillus in alleviating gut-related disorders or metabolic diseases [7,8].”
ResultMasheghati, F., Asgharzadeh, M. R., Jafari, A., Masoudi, N., & Maleki, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122529 · Cited by 39
Ijiri, M., Fujiya, M., Konishi, H., Tanaka, H., Ueno, N., Kashima, S., Moriichi, K., Sasajima, J., Ikuta, K., & Okumura, T. (2017) · Tumor Biology · doi:10.1177/1010428317711311 · Cited by 34
The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer
Chen, C., & Li, H. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2002.02032 · Cited by 36
“Additionally, it is found that ferrichrome is equal to or even better than anticancer agents, such as 5-FU and cisplatin, in anti-tumor effect against CRC cells [43].”
Background
Metadata
- Authors
- Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., Ikuta, K., Akutsu, H., Tanabe, H., & Kohgo, Y.
- Affiliations
- Asahikawa Medical University (JP)
- International University of Health and Welfare Hospital (JP)
- Corresponding author
- Fujiya, Mikihiro
- ORCID
- Venue
- Nature Communications
- Published
- 2016-08-10
- Volume
- 7
- Issue
- 1
- Pages
- 12365-12365
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4987524
- OpenAlex
- W2491844534
- Cited by
- 287
- References
- 20
- Citations by year
- 2026: 15 · 2025: 36 · 2024: 38 · 2023: 39 · 2022: 35 · 2021: 51 · 2020: 28 · 2019: 19 · 2018: 9 · 2017: 16 · 2016: 1
- FWCI
- 18.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Health, Labour and Welfare (26460956)
- Japan Society for the Promotion of Science (26460956, 25460923, 16H06607)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- ferrichrome, probiotics, Lactobacillus casei, colon cancer, apoptosis, JNK signaling, c-Jun N-terminal kinase, tumor suppression, culture supernatant, anticancer activity, gene expression profiling
- MeSH terms
- Animals, Antineoplastic Agents, Cell Survival, Cisplatin, Colon, Colonic Neoplasms, Ferrichrome, Fluorouracil, Humans, Lacticaseibacillus casei, Male, Mice, Inbred BALB C, Mice, Nude, Mass Spectrometry, Up-Regulation, Treatment Outcome, Apoptosis, Disease Progression, Probiotics, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, JNK Mitogen-Activated Protein Kinases, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.